Soluble thrombomodulin as a predictor of incident coronary heart disease and symptomless carotid artery atherosclerosis in the Atherosclerosis Risk in Communities (ARIC) Study: A case-cohort study

Lancet

Volumn 353, Issue 9166, 1999, Pages 1729-1734

  Salomaa, Veikko ^a   Matei, Carmen ^b   Aleksic, Nena ^b   Sansores Garcia, Leticia ^b   Folsom, Aaron R ^c   Juneja, Harinder ^b   Chambless, Lloyd E ^d   Wu, Kenneth K ^b  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY OF TEXAS   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; THROMBOMODULIN;

ARTICLE; ATHEROSCLEROSIS; BLOOD CLOTTING; CAROTID ARTERY DISEASE; CAUCASIAN; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FOLLOW UP; HUMAN; HUMAN CELL; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; NEGRO; PREDICTION; PRIORITY JOURNAL; PUBLIC HEALTH; RISK ASSESSMENT;

EID: 0033594760     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(98)09057-6     Document Type: Article

References (29)

1. Sadler JE. Thrombomodulin structure and function. Thromb Haemost 1997; 78: 392-95.
2. Esmon CT. Thrombomodulin as a model of molecular mechanisms that modulate protease specificity and function at the vessel surface. Faseb J 1995; 9: 946-55.
3. Ishii H, Majerus PW. Thrombomodulin is present in human plasma and urine. J Clin Invest 1985; 76: 2178-81.
4. Ishii H, Uchiyama H, Kazama M. Soluble thrombomodulin antigen in conditioned medium is increased by damage of endothelial cells. Thromb Haemost 1991; 65: 618-23.
5. Blann AD, Admiral J, McCollum CN. Prognostic value of increased soluble thrombomodulin and increased soluble E-selectin in ischaemic heart disease. Eur J Haematol 1997; 59: 115-20.
6. Peter K, Nawroth P, Conradt C, et al. Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulsting intercellular adhesion molecule-1, E-selectin, P-selectin, and thrombomodulin. Arterioscler Thromb Vasc Biol 1997; 17: 505-12.
7. Inukai T, Fujiwara Y, Tayama K, Aso Y, Takemura Y. Clinical significance of measurements of urinary and serum thrombomodulin in patients with non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 1996; 33: 99-104.
8. Ireland H, Kunz G, Kyriakoulis K, Stubbs PJ, Lane DA. Thrombomodulin gene mutations associated with myocardial infarction. Circulation 1997; 96: 15-18.
9. Esmon CT. Defects in natural anticoagulant pathways as potential risk factors for myocardial infarction. Circulation 1997; 96: 9-11.
10. Öhlin A-K, Norlund L, Marlar RA. Thrombomodulin gene variations and thromboembolic disease. Thromb Haemost 1997; 78: 396-400.
11. Doggen CJM, Kunz G, Rosendaal FR, et al. A mutation in the thrombomodulin gene, 127G to A coding for ala25Thr, and the risk of myocardial infarction in men. Thromb Haemost 1998; 80: 743-48.
12. Jansson JH, Boman K, Brannstrom M, Nilsson TK. High concentration of thrombomodulin in plasma is associated with hemorrhage. A prospective study in patients receiving long-term anticoagulant treatment. Circulation 1997; 96: 2938-43.
13. The ARIC Investigators. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. Am J Epidemiol 1989; 129: 687-702.
14. Folsom AR, Wu KK, Rosamond WD, Sharrett AR, Chambless LE. Prospective study of hemostatic factors and incidence of coronary heart disease. The Atherosclerosis Risk in Communities (ARIC) Study. Circulation 1997; 96: 1102-08.
15. Papp AC, Hatzakis H, Bracey A, Wu KK. ARIC hemostasis study I: development of blood collection and processing system suitable for multicenter hemostatic studies. Thromb Haemost 1989; 61: 15-19.
16. Prentice RL. A case-cohort design for epidemiological cohort studies and disease prevention risk. Biometrika 1986; 73: 1-1.
17. White AD, Folsom AR, Chambless LE, et al. Community surveillance of coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) Study: methods and initial two years experience. J Clin Epidemiol 1996; 49: 223-33.
18. Rosamond WD, Chambless LE, Folsom AR, et al. Trends in coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study, 1987 to 1994. N Engl J Med 1998; 339: 861-67.
19. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 1986; 74: 1339-406.
20. Bond MG, Barnes RW, Riley WA, et al. High-resolution B-mode ultrasound scanning methods in the Atherosclerosis Risk in Communities (ARIC). J Neuroimag 1991; 1: 68-73.
21. Riley WA, Barnes RW, Bond MG, Evans G, Chambless LE, Heiss G. High-resolution B-mode ultrasound reading methods in the Atherosclerosis Risk in Communities (ARIC) cohort. J Neuroimag 1991; 1: 168-72.
22. Atherosclerosis Risk in Communities Study Manual 9. Hemostatis determinations. Chapel Hill, NC: National Heart Lung and Blood Institute of the National Institutes of Health, Collaborative Studies Coordinating Center, University of North Carolina, 1987.
23. Barlow WE. Robust variance estimation for the case-cohort design. Biometrics 1994; 50: 1064-72.
24. Blann AD, Seigneur M, Steiner M, Boisseau MR, McCollum CN. Circulating endothelial cell markers in peripheral vascular disease: relationship to the location and extent of atherosclerotic disease. Eur J Clin Invest 1997; 27: 916-21.
25. Norlund L, Holm J, Zoller B, Öhlin A-K. A common thrombomodulin amino acid dimorphism is associated with myocardial infarction. Thromb Haemost 1997; 77: 248-51.
26. Brandt JT. Measurement of factor VIII. A potential risk for vascular disease. Arch Pathol Lab Med 1993; 117: 48-51.
27. Ibbotson SH, Walmsley D, Davies JA, Grant PJ. Generation of thrombin activity in relation to factor VIII:C concentrations and vascular complications in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1992; 35: 863-67.
28. Catella-Lawson F. Direct thrombin inhibitors in cardiovascular disease. Coron Artery Dis 1997; 8: 105-11.
29. Mohri M, Suzuki M, Sugimoto E, Sata M, Yamamoto S, Maruyama I. Effects of recombinant human soluble thrombomodulin (rhs-TM) on clot-induced coagulation in human plasma. Thromb Haemost 1998; 80: 925-29.